This prospective cohort study assessed four different degrees of hepatic steatosis in CHB patients to investigate the effects of hepatic steatosis on CHB pathology and whether hepatic steatosis affects the efficacy of PEG-IFNα-2a. Here, IFNA2 is linked to Hepatic steatosis.